We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · August 18, 2020

Prostate-Specific Membrane Antigen–Directed Focal Stereotactic Reirradiation for Locally Recurrent Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics


Additional Info

Disclosure statements are available on the authors' profiles:

International Journal of Radiation Oncology*Biology*Physics
Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer
Int. J. Radiat. Oncol. Biol. Phys 2020 Jul 11;[EPub Ahead of Print], S Bergamin, T Eade, A Kneebone, J Booth, E Hsiao, GP Schembri, K Szymura, A Le, C Kwong, C Brown, J Hunter, G Hruby

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading